Abstract
Eighteen psychiatric inpatients who fulfilled DSM-III criteria for major depression and who had a positive dexamethasone suppression test after admission were later retested. Of the 13 patients who exhibited cortisol suppression at discharge, two relapsed within 6 months; five remained nonsuppressors at discharge, and all either required further inpatient care or were symptomatic within 2 weeks to 4 months. Continued cortisol nonsuppression was thus associated with poor clinical response or high risk of relapse.
| Original language | English |
|---|---|
| Pages (from-to) | 247-249 |
| Number of pages | 3 |
| Journal | American Journal of Psychiatry |
| Volume | 141 |
| Issue number | 2 |
| State | Published - Jan 1 1984 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Psychiatry and Mental health
Cite this
Correlation between the dexamethasone suppression test in depressed patients and clinical response. / Nemeroff, Charles; Evans, D. L.
In: American Journal of Psychiatry, Vol. 141, No. 2, 01.01.1984, p. 247-249.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Correlation between the dexamethasone suppression test in depressed patients and clinical response
AU - Nemeroff, Charles
AU - Evans, D. L.
PY - 1984/1/1
Y1 - 1984/1/1
N2 - Eighteen psychiatric inpatients who fulfilled DSM-III criteria for major depression and who had a positive dexamethasone suppression test after admission were later retested. Of the 13 patients who exhibited cortisol suppression at discharge, two relapsed within 6 months; five remained nonsuppressors at discharge, and all either required further inpatient care or were symptomatic within 2 weeks to 4 months. Continued cortisol nonsuppression was thus associated with poor clinical response or high risk of relapse.
AB - Eighteen psychiatric inpatients who fulfilled DSM-III criteria for major depression and who had a positive dexamethasone suppression test after admission were later retested. Of the 13 patients who exhibited cortisol suppression at discharge, two relapsed within 6 months; five remained nonsuppressors at discharge, and all either required further inpatient care or were symptomatic within 2 weeks to 4 months. Continued cortisol nonsuppression was thus associated with poor clinical response or high risk of relapse.
UR - http://www.scopus.com/inward/record.url?scp=0021323738&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021323738&partnerID=8YFLogxK
M3 - Article
C2 - 6691487
AN - SCOPUS:0021323738
VL - 141
SP - 247
EP - 249
JO - American Journal of Psychiatry
JF - American Journal of Psychiatry
SN - 0002-953X
IS - 2
ER -